BRCA1 and ovarian carcinoma: Gaps as a determinant of PARPi response were in part highlighted by the comparison between cells deficient in the hereditary breast and ovarian cancer genes BRCA1 or FANCJ. Cells deficient in either gene display similar defects in HR and fork protection14–16.